Literature DB >> 17989336

Utility of composite reference standards and latent class analysis in evaluating the clinical accuracy of diagnostic tests for pertussis.

Andrew L Baughman1, Kristine M Bisgard, Margaret M Cortese, William W Thompson, Gary N Sanden, Peter M Strebel.   

Abstract

Numerous evaluations of the clinical sensitivity and specificity of PCR and serologic assays for Bordetella pertussis have been hampered by the low sensitivity of culture, the gold standard test, which leads to biased accuracy estimates. The bias can be reduced by using statistical approaches such as the composite reference standard (CRS) (e.g., positive if culture or serology positive; negative otherwise) or latent class analysis (LCA), an internal reference standard based on a statistical model. We illustrated the benefits of the CRS and LCA approaches by reanalyzing data from a 1995 to 1996 study of cough illness among 212 patients. The accuracy of PCR in this study was evaluated using three reference standards: culture, CRS, and LCA. Using specimens obtained 0 to 34 days after cough onset, estimates of the sensitivity of PCR obtained using CRS (47%) and LCA (34%) were lower than the culture-based estimate (62%). The CRS and LCA approaches, which utilized more than one diagnostic marker of pertussis, likely produced more accurate reference standards than culture alone. In general, the CRS approach is simple, with a well-defined disease status. LCA requires statistical modeling but incorporates more indicators of disease than CRS. When three or more indicators of pertussis are available, these approaches should be used in evaluations of pertussis diagnostic tests.

Entities:  

Mesh:

Year:  2007        PMID: 17989336      PMCID: PMC2223853          DOI: 10.1128/CVI.00223-07

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  47 in total

1.  Establishment of diagnostic cutoff points for levels of serum antibodies to pertussis toxin, filamentous hemagglutinin, and fimbriae in adolescents and adults in the United States.

Authors:  Andrew L Baughman; Kristine M Bisgard; Kathryn M Edwards; Dalya Guris; Michael D Decker; Kathy Holland; Bruce D Meade; Freyja Lynn
Journal:  Clin Diagn Lab Immunol       Date:  2004-11

2.  Bias in the evaluation of DNA-amplification tests for detecting Chlamydia trachomatis.

Authors:  J Schachter
Journal:  Stat Med       Date:  1998-07-15       Impact factor: 2.373

3.  Two different worlds we live in.

Authors:  J Schachter
Journal:  Clin Infect Dis       Date:  1998-11       Impact factor: 9.079

4.  Can we do better than discrepant analysis for new diagnostic test evaluation?

Authors:  W C Miller
Journal:  Clin Infect Dis       Date:  1998-11       Impact factor: 9.079

5.  Estimation of test sensitivity and specificity when disease confirmation is limited to positive results.

Authors:  S D Walter
Journal:  Epidemiology       Date:  1999-01       Impact factor: 4.822

Review 6.  Evaluation of diagnostic tests without gold standards.

Authors:  S L Hui; X H Zhou
Journal:  Stat Methods Med Res       Date:  1998-12       Impact factor: 3.021

7.  Bias in discrepant analysis: when two wrongs don't make a right.

Authors:  W C Miller
Journal:  J Clin Epidemiol       Date:  1998-03       Impact factor: 6.437

8.  Comparison of PCR, culture, and direct fluorescent-antibody testing for detection of Bordetella pertussis.

Authors:  M J Loeffelholz; C J Thompson; K S Long; M J Gilchrist
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

9.  Evaluation of PCR for diagnosis of Bordetella pertussis and Bordetella parapertussis infections.

Authors:  L Lind-Brandberg; C Welinder-Olsson; T Lagergård; J Taranger; B Trollfors; G Zackrisson
Journal:  J Clin Microbiol       Date:  1998-03       Impact factor: 5.948

Review 10.  Defining pertussis epidemiology: clinical, microbiologic and serologic perspectives.

Authors:  James D Cherry; Emmanuel Grimprel; Nicole Guiso; Ulrich Heininger; Jussi Mertsola
Journal:  Pediatr Infect Dis J       Date:  2005-05       Impact factor: 2.129

View more
  32 in total

Review 1.  Methods and recommendations for evaluating and reporting a new diagnostic test.

Authors:  A S Hess; M Shardell; J K Johnson; K A Thom; P Strassle; G Netzer; A D Harris
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-03-29       Impact factor: 3.267

2.  American College of Rheumatology classification criteria for Sjögren's syndrome: a data-driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance cohort.

Authors:  S C Shiboski; C H Shiboski; L A Criswell; A N Baer; S Challacombe; H Lanfranchi; M Schiødt; H Umehara; F Vivino; Y Zhao; Y Dong; D Greenspan; A M Heidenreich; P Helin; B Kirkham; K Kitagawa; G Larkin; M Li; T Lietman; J Lindegaard; N McNamara; K Sack; P Shirlaw; S Sugai; C Vollenweider; J Whitcher; A Wu; S Zhang; W Zhang; J S Greenspan; T E Daniels
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-04       Impact factor: 4.794

3.  Type-specific identification of anogenital herpes simplex virus infections by use of a commercially available nucleic acid amplification test.

Authors:  Barbara Van Der Pol; Terri Warren; Stephanie N Taylor; Mark Martens; Keith R Jerome; Leandro Mena; Joel Lebed; Savita Ginde; Paul Fine; Edward W Hook
Journal:  J Clin Microbiol       Date:  2012-08-08       Impact factor: 5.948

4.  Xpert MTB/RIF: a new pillar in diagnosis of extrapulmonary tuberculosis?

Authors:  Viral Vadwai; Catharina Boehme; Pamela Nabeta; Anjali Shetty; David Alland; Camilla Rodrigues
Journal:  J Clin Microbiol       Date:  2011-05-18       Impact factor: 5.948

5.  A Comparative Evaluation of Different Diagnostic Modalities in the Diagnosis of Typhoid Fever Using a Composite Reference Standard: A Tertiary Hospital Based Study in Central India.

Authors:  Veena Maheshwari; Navinchandra Motiram Kaore; Vijay Kumar Ramnani; Sheil Sarda
Journal:  J Clin Diagn Res       Date:  2016-10-01

6.  Diagnostic performance tests for suspected scaphoid fractures differ with conventional and latent class analysis.

Authors:  Geert A Buijze; Wouter H Mallee; Frank J P Beeres; Timothy E Hanson; Wesley O Johnson; David Ring
Journal:  Clin Orthop Relat Res       Date:  2011-09-30       Impact factor: 4.176

7.  Use of population health data to refine diagnostic decision-making for pertussis.

Authors:  Andrew M Fine; Ben Y Reis; Lise E Nigrovic; Donald A Goldmann; Tracy N Laporte; Karen L Olson; Kenneth D Mandl
Journal:  J Am Med Inform Assoc       Date:  2010 Jan-Feb       Impact factor: 4.497

8.  Using a bayesian latent class model to evaluate the utility of investigating persons with negative polymerase chain reaction results for pertussis.

Authors:  Gillian A M Tarr; Jens C Eickhoff; Ruth Koepke; Daniel J Hopfensperger; Jeffrey P Davis; James H Conway
Journal:  Am J Epidemiol       Date:  2013-06-04       Impact factor: 4.897

Review 9.  Estimation of diagnostic test accuracy without full verification: a review of latent class methods.

Authors:  John Collins; Minh Huynh
Journal:  Stat Med       Date:  2014-06-09       Impact factor: 2.373

Review 10.  Rapid tests for the diagnosis of visceral leishmaniasis in patients with suspected disease.

Authors:  Marleen Boelaert; Kristien Verdonck; Joris Menten; Temmy Sunyoto; Johan van Griensven; Francois Chappuis; Suman Rijal
Journal:  Cochrane Database Syst Rev       Date:  2014-06-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.